NAMES AND DATABASE IDS
NAMES AND DATABASE IDS
Names Database IDs
IUPAC name
|
4-amino-N-(pyridin-2-yl)benzene-1-sulfonamide
|
|
|
IUPAC Traditional name
|
|
Brand Name
|
Adiplon
|
Coccoclase
|
Dagenan
|
Eubasin
|
Eubasinum
|
Haptocil
|
M and B 693
|
Piridazol
|
Plurazol
|
Pyriamid
|
Pyridazol
|
Relbapiridina
|
Ronin
|
Septipulmon
|
Streptosilpyridine
|
Sulfidin
|
Sulfidine
|
Thioseptal
|
Trianon
|
|
|
Synonyms
|
4-Amino-N-2-pyridinyl-benzenesulfonamide
|
N1-(Pyridin-2-yl)sulfanilamide
|
4-Amino-N-pyridin-2-ylbenzenesulfonamide
|
4-Amino-N-[2-pyridyl]benzene sulfonamide
|
N1-(Pyridin-2-yl)sulfanilamide
|
Sulfapyridine
|
Sulfapyridine (Dagenan)
|
4-(2-Pyridinylsulfonyl)aniline
|
4-[(2-Pyridylamino)sulfonyl]aniline
|
N(sup 1)-2-Pyridylsulfanilamide
|
N(sup1)-Pyridylsulfanilamide
|
N-2-Pyridylsulfanilamide
|
N1-2-Pyridylsulfanilamide
|
Sulphapyridine
|
Sulfapyridine
|
2-Sulfanilamidopyridin
|
2-Sulfanilamidopyridine
|
2-Sulfanilylaminopyridine
|
2-Sulfapyridine
|
4-Amino-N-2-pyridinylbenzenesulfonamide
|
Adiplon
|
Coccoclase
|
Dagenan
|
Eubasin
|
Eubasinum
|
Haptocil
|
Sulfidine
|
Thioseptal
|
Trianon
|
4-氨基-N-[2-吡啶基]苯磺酰胺
|
N1-(吡啶-2-基)磺胺
|
磺胺吡啶
|
|
|
CAS Number
|
|
EC Number
|
|
MDL Number
|
|
Beilstein Number
|
|
PubChem SID
|
|
PubChem CID
|
|
CHEBI ID
|
|
ATC CODE
|
|
CHEMBL
|
|
Chemspider ID
|
|
DrugBank ID
|
|
KEGG ID
|
|
Unique Ingredient Identifier
|
|
Wikipedia Title
|
|
Medline Plus
|
|
DATA SOURCES
DATA SOURCES
All Sources Commercial Sources Non-commercial Sources
CALCULATED PROPERTIES
CALCULATED PROPERTIES
JChem
ALOGPS 2.1
Acid pKa
|
6.2384915
|
H Acceptors
|
4
|
H Donor
|
2
|
LogD (pH = 5.5)
|
0.94377524
|
LogD (pH = 7.4)
|
0.24198662
|
Log P
|
1.0087702
|
Molar Refractivity
|
65.7472 cm3
|
Polarizability
|
25.447033 Å3
|
Polar Surface Area
|
85.08 Å2
|
Rotatable Bonds
|
2
|
Lipinski's Rule of Five
|
true
|
Log P
|
0.84
|
LOG S
|
-3.03
|
Solubility (Water)
|
2.35e-01 g/l
|
DETAILS
DETAILS
MP Biomedicals
DrugBank
Wikipedia
Sigma Aldrich
TRC
DrugBank -
DB00891
|
Item |
Information |
Drug Groups
|
approved |
Description
|
Antibacterial, potentially toxic, used to treat certain skin diseases. [PubChem] |
Indication |
For the treatment of dermatitis herpetiformis, benign mucous membrane pemphigoid and pyoderma gangrenosum |
Pharmacology |
Sulfapyridine is a sulfonamide antibiotic. The sulfonamides are synthetic bacteriostatic antibiotics with a wide spectrum against most gram-positive and many gram-negative organisms. However, many strains of an individual species may be resistant. Sulfonamides inhibit multiplication of bacteria by acting as competitive inhibitors of p-aminobenzoic acid in the folic acid metabolism cycle. Bacterial sensitivity is the same for the various sulfonamides, and resistance to one sulfonamide indicates resistance to all. Most sulfonamides are readily absorbed orally. However, parenteral administration is difficult, since the soluble sulfonamide salts are highly alkaline and irritating to the tissues. The sulfonamides are widely distributed throughout all tissues. High levels are achieved in pleural, peritoneal, synovial, and ocular fluids. Although these drugs are no longer used to treat meningitis, CSF levels are high in meningeal infections. Their antibacterial action is inhibited by pus. |
Toxicity |
LD50 is 15800 mg/kg (orally in rats). |
Affected Organisms |
• |
Humans and other mammals |
|
Biotransformation |
Hepatic. |
Absorption |
Approximately 60-80% |
Half Life |
6-14 hours. |
Protein Binding |
Approximately 50% bound to plasma proteins. |
External Links |
|
|
REFERENCES
REFERENCES
From Suppliers
Google Scholar
PubMed
Google Books
- • Wien, R., et al.: J. Pharmacol. Exp. Ther., 84, 211 (1945)
- • Stone, O.J., et al.: Med. Hypotheses, 31, 99 (1945)
- • Elder, M.J., et al.: Br. J. Ophthalmol., 80, 549 (1945)
- Searching...Please wait...
PATENTS
PATENTS
PubChem Patent
Google Patent